Effects of shock wave therapy to the digital ulcers of Scleroderma

Effects of shock wave therapy to the digital ulcers of Scleroderma - Effects of shock wave therapy to the digital ulcers of Scleroderma

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012349

Enrollment

Registered

2013-11-19

Start date

2013-12-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scleroderma

Interventions

Extracorporeal shock waves therapy ordinary treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: age of over 18y/o SSC diagnosed with ACR criteria Written informed consent to participate.

Exclusion criteria

Exclusion criteria: Treated with new drug for ulcer prior 4 weeks. Patients with sevear heart disease. Patients with infectious disease. The pregnant and lactating female, female who has possibility of the pregnancy. Patients who were judged inappropriate to entry this study by physician.

Design outcomes

Primary

Measure	Time frame
The reduction of numbers of ulcers at 8 week.	—

Secondary

Measure	Time frame
The reduction of numbers of ulcers at 4, 12 week. The reduciton of number of big ulcer (more than 5mm) The reduction ratio of ulcer at 4, 8, 12 week. Emergence of new ulcer Improvement rate of patient's VAS improvement of HAQ Improvemnet of EQ5D Improvement of blood flow measeured by themography	—

Countries

Japan

Contacts

Public ContactTomonori

Tohoku university hospital Hematology and Rheumatology

tishii@med.tohoku.ac.jp022-717-7165

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026